LENZ Therapeutics, Inc. (LENZ)
LENZ Stock Price Chart
Explore LENZ Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze LENZ price movements and trends.
LENZ Company Profile
Discover essential business fundamentals and corporate details for LENZ Therapeutics, Inc. (LENZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Mar 2024
Employees
6.00
Website
https://www.lenz-tx.comCEO
Evert Schimmelpennink
Description
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
LENZ Financial Timeline
Browse a chronological timeline of LENZ Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is -$1.07, while revenue estimate is $2.41m.
Earnings released on 11 May 2026
EPS came in at -$1.32 falling short of the estimated -$1.10 by -20.00%, while revenue for the quarter reached $1.90m , beating expectations by +8.08%.
Earnings released on 24 Mar 2026
EPS came in at -$1.16 falling short of the estimated -$0.91 by -27.47%, while revenue for the quarter reached $1.59m , missing expectations by -48.50%.
Earnings released on 5 Nov 2025
EPS came in at -$0.59 surpassing the estimated -$0.67 by +11.94%, while revenue for the quarter reached $12.50m , beating expectations by +309.95%.
Earnings released on 30 Jul 2025
EPS came in at -$0.53 surpassing the estimated -$0.58 by +8.62%, while revenue for the quarter reached $5.00m , beating expectations by +600.00%.
Earnings released on 7 May 2025
EPS came in at -$0.53 surpassing the estimated -$0.55 by +3.64%.
Earnings released on 19 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.42 by -9.52%.
Earnings released on 6 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.47 by +19.15%.
Earnings released on 14 Aug 2024
EPS came in at -$0.40 surpassing the estimated -$0.49 by +18.37%.
Earnings released on 8 May 2024
EPS came in at -$3.53 falling short of the estimated -$0.84 by -320.24%.
Dividend declared on 22 Mar 2024
A dividend of $1.03 per share was announced, adjusted to $7.21.
Stock split effective on 22 Mar 2024
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 15 Mar 2024
A dividend of $1.03 per share was announced, adjusted to $7.21.
Earnings released on 27 Feb 2024
EPS came in at -$0.40 falling short of the estimated -$0.13 by -207.69%.
Earnings released on 13 Nov 2023
EPS came in at -$0.19 surpassing the estimated -$0.25 by +24.00%.
Earnings released on 29 Jun 2023
EPS came in at -$6.82 falling short of the estimated -$6.79 by -0.49%.
Earnings released on 30 Mar 2023
EPS came in at -$3.00 falling short of the estimated -$2.41 by -24.54%.
Earnings released on 30 Dec 2022
EPS came in at -$3.09 surpassing the estimated -$3.45 by +10.54%.
Earnings released on 29 Sept 2022
EPS came in at -$3.13 falling short of the estimated -$3.11 by -0.63%.
Earnings released on 29 Jun 2022
EPS came in at -$3.42 surpassing the estimated -$3.44 by +0.57%.
Earnings released on 30 Mar 2022
EPS came in at -$3.39 .
Earnings released on 30 Dec 2021
EPS came in at -$2.28 surpassing the estimated -$2.73 by +16.33%.
Earnings released on 29 Sept 2021
EPS came in at -$1.76 .
LENZ Stock Performance
Access detailed LENZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
